Bright Minds Biosciences Inc.
DRUG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827401
No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Bright Minds Biosciences Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 10 | 14 | +4 |
| Shares | 487.7K | 412.9K | −74.8K (−15.3%) |
| Value | $399.0K | $509.0K | +$110.0K (+27.6%) |
New holders (6)
Institutions that held Bright Minds Biosciences Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 11,069 | $14.0K | 0.00% |
| First Republic Investment Management, Inc. | 11,329 | $14.0K | 0.00% |
| Bank of America Corp | 10,655 | $13.0K | 0.00% |
| Two Sigma Securities, LLC | 10,204 | $13.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 629 | $1.00K | 0.00% |
| Advisor Group Holdings, Inc. | 400 | $0 | 0.00% |
Sold out (2)
Institutions that held Bright Minds Biosciences Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ikarian Capital, LLC | 105,958 | $86.0K |
| Boothbay Fund Management, LLC | 11,040 | $9.00K |